Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H24O6 |
Molecular Weight | 396.4331 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C\C(=O)\C=C\C=C\C2=CC(OC)=C(O)C(OC)=C2)=CC(OC)=C1
InChI
InChIKey=LJSMCOGLALRQKD-BISOHRNISA-N
InChI=1S/C23H24O6/c1-26-19-11-17(12-20(15-19)27-2)9-10-18(24)8-6-5-7-16-13-21(28-3)23(25)22(14-16)29-4/h5-15,25H,1-4H3/b7-5+,8-6+,10-9+
Molecular Formula | C23H24O6 |
Molecular Weight | 396.4331 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:30:32 GMT 2023
by
admin
on
Sat Dec 16 19:30:32 GMT 2023
|
Record UNII |
TNM7KA4LB3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
870922
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
870822
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
876722
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
154728220
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
PRIMARY | |||
|
2663700-89-6
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
PRIMARY | |||
|
TNM7KA4LB3
Created by
admin on Sat Dec 16 19:30:32 GMT 2023 , Edited by admin on Sat Dec 16 19:30:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|